BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35003100)

  • 21. Coexpression of Helios in Foxp3
    Yu WQ; Ji NF; Gu CJ; Wang YL; Huang M; Zhang MS
    Dis Markers; 2021; 2021():5574472. PubMed ID: 34257746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.
    Angin M; Klarenbeek PL; King M; Sharma SM; Moodley ES; Rezai A; Piechocka-Trocha A; Toth I; Chan AT; Goulder PJ; Ndung'u T; Kwon DS; Addo MM
    PLoS One; 2014; 9(2):e86920. PubMed ID: 24498287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast and Efficient Genome Editing of Human FOXP3
    Van Zeebroeck L; Arroyo Hornero R; Côrte-Real BF; Hamad I; Meissner TB; Kleinewietfeld M
    Front Immunol; 2021; 12():655122. PubMed ID: 34408743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
    Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
    Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
    Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin/AdipoR1 Axis Promotes IL-10 Release by Human Regulatory T Cells.
    Ramos-Ramírez P; Malmhäll C; Tliba O; Rådinger M; Bossios A
    Front Immunol; 2021; 12():677550. PubMed ID: 34084174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
    Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
    Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function.
    Herrath J; Müller M; Amoudruz P; Janson P; Michaëlsson J; Larsson PT; Trollmo C; Raghavan S; Malmström V
    Eur J Immunol; 2011 Aug; 41(8):2279-90. PubMed ID: 21607944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions.
    Raffin C; Pignon P; Celse C; Debien E; Valmori D; Ayyoub M
    J Immunol; 2013 Nov; 191(9):4619-27. PubMed ID: 24068664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Regulatory T Cell-Based Therapy Relies on Inhibition of T Cell Effector Function and Enrichment of FOXP3+ Cells in a Humanized Mouse Model of Skin Inflammation.
    Landman S; de Oliveira VL; Peppelman M; Fasse E; van Rijssen E; Bauland SC; van Erp P; Joosten I; Koenen HJPM
    J Immunol Res; 2020; 2020():7680131. PubMed ID: 32509883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin.
    Beermann JL; Thiesler CT; Dringenberg U; Alter C; Kuhs S; Velaga S; Ukena SN; Franzke A
    Transpl Immunol; 2017 Dec; 45():29-34. PubMed ID: 28870639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patients.
    Liu MF; Jin C; Wu T; Chen EH; Lu M; Qin HL
    Immunol Res; 2021 Jun; 69(3):275-284. PubMed ID: 33959834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells.
    Dijke IE; Hoeppli RE; Ellis T; Pearcey J; Huang Q; McMurchy AN; Boer K; Peeters AM; Aubert G; Larsen I; Ross DB; Rebeyka I; Campbell A; Baan CC; Levings MK; West LJ
    Am J Transplant; 2016 Jan; 16(1):58-71. PubMed ID: 26414799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.